Expert Review of Anticancer Therapy

2.8(top 20%)

impact factor

2.5K(top 10%)

papers

54.4K(top 5%)

citations

82(top 10%)

h-index

3.1(top 20%)

extended IF

3.5K

all documents

58.7K

doc citations

118(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Current and future therapeutic approaches for osteosarcoma	Expert Review of Anticancer Therapy	2018	571
2	HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies	Expert Review of Anticancer Therapy	2011	384
3	Chemotherapy resistance in osteosarcoma: current challenges and future directions	Expert Review of Anticancer Therapy	2006	343
4	The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care	Expert Review of Anticancer Therapy	2018	324
5	Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor	Expert Review of Anticancer Therapy	2007	310
6	Overview and recent advances in the treatment of neuroblastoma	Expert Review of Anticancer Therapy	2017	301
7	Management of soft tissue sarcomas of the extremities	Expert Review of Anticancer Therapy	2004	295
8	A new understanding in the epidemiology of melanoma	Expert Review of Anticancer Therapy	2010	273
9	Nonhistone protein acetylation as cancer therapy targets	Expert Review of Anticancer Therapy	2010	262
10	Inflammation in the development of lung cancer: epidemiological evidence	Expert Review of Anticancer Therapy	2008	245
11	Metastatic osteosarcoma: a challenging multidisciplinary treatment	Expert Review of Anticancer Therapy	2016	237
12	Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors	Expert Review of Anticancer Therapy	2010	223
13	Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy	Expert Review of Anticancer Therapy	2009	211
14	Head and neck cancer: past, present and future	Expert Review of Anticancer Therapy	2006	201
15	Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer	Expert Review of Anticancer Therapy	2018	188
16	A comprehensive review of protein kinase inhibitors for cancer therapy	Expert Review of Anticancer Therapy	2018	186
17	Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases	Expert Review of Anticancer Therapy	2010	182
18	Nanotechnology for targeted cancer therapy	Expert Review of Anticancer Therapy	2007	178
19	The role of platelet activation in tumor metastasis	Expert Review of Anticancer Therapy	2008	167
20	Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles	Expert Review of Anticancer Therapy	2016	164
21	Oncolytic viruses: a novel form of immunotherapy	Expert Review of Anticancer Therapy	2008	158
22	Current systemic therapy for metastatic melanoma	Expert Review of Anticancer Therapy	2009	152
23	Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade	Expert Review of Anticancer Therapy	2012	152
24	The role of Gliadel wafers in the treatment of high-grade gliomas	Expert Review of Anticancer Therapy	2013	145
25	Development of histone deacetylase inhibitors for cancer treatment	Expert Review of Anticancer Therapy	2007	141
26	Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis	Expert Review of Anticancer Therapy	2004	139
27	Autophagy and endocrine resistance in breast cancer	Expert Review of Anticancer Therapy	2011	139
28	Anti-GD2 immunotherapy for neuroblastoma	Expert Review of Anticancer Therapy	2017	133
29	Stathmin 1: a novel therapeutic target for anticancer activity	Expert Review of Anticancer Therapy	2008	132
30	Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review	Expert Review of Anticancer Therapy	2017	132
31	MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century	Expert Review of Anticancer Therapy	2009	131
32	Recent advances in the prevention and treatment of skin cancer using photodynamic therapy	Expert Review of Anticancer Therapy	2010	131
33	Screening of colorectal cancer: present and future	Expert Review of Anticancer Therapy	2017	131
34	MYC in breast tumor progression	Expert Review of Anticancer Therapy	2008	130
35	Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route	Expert Review of Anticancer Therapy	2019	129
36	Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma	Expert Review of Anticancer Therapy	2004	124
37	Present and potential future issues in glioblastoma treatment	Expert Review of Anticancer Therapy	2006	123
38	Current epidemiological trends and surveillance issues in brain tumors	Expert Review of Anticancer Therapy	2001	119
39	Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial	Expert Review of Anticancer Therapy	2009	119
40	New treatment strategies for malignant gliomas	Expert Review of Anticancer Therapy	2006	118
41	The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review	Expert Review of Anticancer Therapy	2017	117
42	Optimizing treatment in recurrent epithelial ovarian cancer	Expert Review of Anticancer Therapy	2017	115
43	ROS1 as a ‘druggable’ receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway	Expert Review of Anticancer Therapy	2012	114
44	Lapatinib in the treatment of breast cancer	Expert Review of Anticancer Therapy	2007	111
45	Molecular mechanisms of temozolomide resistance in glioblastoma multiforme	Expert Review of Anticancer Therapy	2012	111
46	Review of image-guided radiation therapy	Expert Review of Anticancer Therapy	2007	110
47	The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy	Expert Review of Anticancer Therapy	2016	110
48	Hydroxyurea: a key player in cancer chemotherapy	Expert Review of Anticancer Therapy	2012	108
49	Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma	Expert Review of Anticancer Therapy	2009	107
50	Mathematical modeling of cancer progression and response to chemotherapy	Expert Review of Anticancer Therapy	2006	106

Scientometrics

Overviews

Citing Bodies

Expert Review of Anticancer Therapy

Top Articles